Abstract:OBJECTIVE:To investigate the relationship between G1958A gene polymorphism of methylenetetrahydrofolate dehydrogenase (MTHFD) and occurrence of congenital heart disease (CHD) in North China.METHODS:One hundred and ninety-two CHD patients and their parents were included in this study as case group in Liaoning Province by birth defect registration cards, and 124 healthy subjects (age and gender matched) and their parents were simultaneously selected from the same geographic area as control. Their gene polymorphism of MTHFD G1958A locus was examined with PCR-RFLP, and serum folic acid and homocysteine (Hcy) levels were tested with radio-immunoassay and fluorescence polarization immunoassay (FPIA).RESULTS:There existed gene polymorphism at MTHFD G1958A locus in healthy subjects living in North China. The percentages of GG, GA, and AA genotype were 57.98%, 35.57%, and 6.45% respectively, and the A allele frequency was 24.23%, which was significantly different from Western population. No difference was observed when comparing genotype distribution and allele frequency between the case and control groups, so was the result from the comparison between genders. The A allele frequency of arterial septal defect patients' mothers (10.87%) was significantly lower than that of controls (28.15%) (P=0.014), with OR=0.31 (95% CI: 0.09-0.84), and no difference in the other subgroups. The percentage of at least one parent carrying A allele in arterial septal defect subgroup (43.48%) was significantly lower than that in controls (69.64%) (P=0.017), with OR=0.34 (95% CI: 0.12-0.92). The analysis of genetic transmission indicated that there was no transmission disequillibrium in CHD nuclear families. Their serum folic acid level was significantly higher than that of controls (P=0.000), and Hcy level of the former was higher than that of the latter with no statistical significance (P>0.05). Serum Hcy and folic acid levels of mothers with gene mutation were lower than those of mothers with no mutation.CONCLUSION:No significant difference of genotype distribution and allele frequency existed between CHD patients and healthy population. MTHFD G1958A mutation in parents (particularly in mother) can decrease the risk of arterial septal defect in offspring. The possible mechanism of protection might be mutation, which can increase MTHFD enzyme activity, folic acid metabolism and homocysteine remethylation, and decrease Hcy level.

Study on the Association Between Reduced Folate Carrier Gene Polymorphism and Congenital Heart Defects and Cleft Lip with or Without Cleft Palate

Genetic Variation of Infant Reduced Folate Carrier (A80G) and Risk of Orofacial Defects and Congenital Heart Defects in China.

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

[Relationship Between Genetic Polymorphisms of RFC1 A80G and Nonsymdromic Cleft Lip with or Without Palate].

Reduced folate carrier gene is a risk factor for neural tube defects in a Chinese population.

Association of Reduced Folate Carrier Gene Polymorphism and Maternal Folic Acid Use with Neural Tube Defects

Interaction Between Maternal Periconceptional Supplementation of Folic Acid and Reduced Folate Carrier Gene Polymorphism of Neural Tube Defects

[A Parental Case Control Study on the Association Between Reduced Folate Carrier Gene Polymorphism and Neural Tube Defects].

Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease

Association of fetal congenital heart diseases with methylenetetrahydrofolate reductase gene polymorphisms

[Epidemiological Study on Reduced Folate Carrier Gene(rfc1 A80G) Polymorphism and Other Risk Factors of Neural Tube Defects].

Association Study for Gene Polymorphism of Folic Acid/homocysteine Metabolic Pathway and Nonsyndromic Cleft Lip with or Without Cleft Palate in Chinese Populations

Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease

[Advances in the Study of the Etiologic Relationship Between Reduced Folate Carrier Gene (RFC1) and Neural Tube and Craniofacial Defects].

Reduced Folate Carrier A80G Polymorphism and Susceptibility to Neural Tube Defects: A Meta-Analysis

Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80 G>A polymorphisms are associated with an increased risk of conotruncal heart defects

Study on Reduced Folate Carrier Gene(rfc1) Polymorphism in the Southern and Northern Chinese Population

Relationship Between Polymorphism of Methylenetetrahydrofolate Dehydrogenase and Congenital Heart Defect.

Family-Based Association Test for Reduced Folate Carrier Gene Polymorphism of Parent and Offspring with Neural Tube Defects

Association of Snps in Genes Involved in Folate Metabolism with the Risk of Congenital Heart Disease

Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: a meta-analysis.